Research goals

ACINETWORK is committed to the design and development of novel glycoconjugate vaccine candidates as treatment against severe and life-threatening infections caused by the multidrug-resistant bacterium Acinetobacter baumannii, a major cause of nosocomial diseases

The research programme is organised in two
interconnected scientific work packages:

Work
package 1
(WP1)

Design, synthesis and characterization of Acinetobacter baumannii polysaccharide-based glycoconjugates.

Biological study of Acinetobacter baumannii polysaccharide-based glycoconjugates.

Work
package 2
(WP2)

Contact form

For more information, please complete the form below

Marie Skłodowska Curie Network
ACINetwork (Project no. 101119795)